Palisade Bio Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:PALI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 May 24BuyUS$4,863Donald WilliamsIndividual1,000US$4.86
24 May 24BuyUS$4,810J. FinleyIndividual1,000US$4.81
06 Feb 24BuyUS$4,692J. FinleyIndividual666.67US$7.04
31 Jan 24BuyUS$6,050Donald WilliamsIndividual666.67US$9.07
31 Jan 24BuyUS$5,590J. FinleyIndividual666.67US$8.38

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PALI?
Owner TypeNumber of SharesOwnership Percentage
Private Companies510.00384%
Individual Insiders22,1961.67%
Institutions23,4531.76%
Hedge Funds125,6929.45%
General Public1,158,12487.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 116.4%.


Top Shareholders

Top 18 shareholders own 12.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.45%
Armistice Capital LLC
125,692US$214.9k351%0.01%
1.01%
J. Finley
13,472US$23.0k0%no data
0.62%
JPMorgan Chase & Co, Brokerage and Securities Investments
8,200US$14.0k0%no data
0.34%
The Vanguard Group, Inc.
4,536US$7.8k0%no data
0.31%
Bridgeway Capital Management, LLC
4,104US$7.0k0%no data
0.29%
Mitchell Jones
3,852US$6.6k0%no data
0.28%
Donald Williams
3,728US$6.4k11.6%no data
0.18%
Yuma Regional Medical Center, Endowment Arm
2,419US$4.1k0%no data
0.17%
Geode Capital Management, LLC
2,296US$3.9k0%no data
0.12%
Tower Research Capital Europe Limited
1,597US$2.7k116%no data
0.064%
Binxian Wei
855US$1.5k83.1%no data
0.022%
Robert McRae
289US$494.30%no data
0.011%
Morgan Stanley, Investment Banking and Brokerage Investments
140US$239.40%no data
0.0075%
Fédération des Caisses Desjardins du Québec, Asset Management Arm
100US$171.00%no data
0.0038%
Fcw Investments Llc
51US$87.30%no data
0.0023%
UBS Asset Management AG
31US$53.0-97.5%no data
0.0016%
Wells Fargo & Company, Securities and Brokerage Investments
21US$35.90%no data
0.00068%
Bank of America Corporation, Asset Management Arm
9US$15.580%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 01:37
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Palisade Bio, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Aydin HuseynovLadenburg Thalmann & Company
Jason McCarthyMaxim Group